Publications

The benefits and risks of maternal RSV vaccination on mortality in South Africa: a modelling study.

Monoi, A; Endo, A; PROCTER, S; LEUBA, S; FLASCHE, S; Jit, M; Maternal RSV vaccine benefit-risk advisory group,; Beutels, P; Cohen, C; Feikin, D; Koltai, M; Madhi, S; Moyes, J; Munywoki, P; Nyiro, J; Nyawanda, B; Sparrow, E; Zar, H;

2025

medRxiv (2025). 10.1101/2025.02.14.25321914.

Population impact of new TB vaccines may depend on efficacy against infectious asymptomatic TB: a modelling study.

TANVIR, H; CLARK, RA; SUMNER, T; HORTON, KC; Prŷs-Jones, TO; Bakker, R; Rade, K; Mave, V; Hatherill, M; Churchyard, G; HOUBEN, RM G J; WHITE, RG;

2025

Cold Spring Harbor Laboratory (2025). 10.1101/2025.03.24.25323816.

The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?.

Andrews, JR; Charalambous, S; Churchyard, G; Cobelens, F; Fernández-Escobar, C; Frick, M; Hanekom, W; Hatherill, M; Hill, PC; Pandey, S; Rangaka, MX; WHITE, RG; Lemos, EF; Da Silva, AM; Croda, J; Garcia-Basteiro, AL;

2025

The Lancet Infectious Diseases (2025). 10.1016/s1473-3099(25)00305-6.

Climate change and tuberculosis: an analytical framework.

SAUNDERS, M; Boccia, D; KHAN, P; Goscè, L; GASPARRINI, A; CLARK, R; Pescarini, J; WHITE, R; HOUBEN, RM G J; Zignol, M; Gebreselassie, N; Finn McQuaid, C;

2025

medRxiv (2025). 10.1101/2025.02.18.25322451.

Vaccination strategies against wild poliomyelitis in polio-free settings: outbreak risk modelling study and cost-effectiveness analysis.

Auzenbergs, M; ABBAS, K; Peak, CM; Voorman, A; Jit, M; O'REILLY, KM;

2025

BMJ global health, (2025).10 3 10.1136/bmjgh-2024-016013.

The delivery of new tuberculosis vaccines to people living with HIV – when to vaccinate?.

SUMNER, T; CLARK, RA; Prys-Jones, TO; Bakker, R; Churchyard, G; WHITE, RG;

2025

BMC Infectious Diseases, (2025).25 1 10.1186/s12879-025-11249-y.

Same but Different: Addressing Vulnerabilities within Diverse Populations and Health Systems through Tailoring Public Health Models. Invited speaker for Glasgow health Economics Seminar Series (GhESS).

FOSS, A;

2025

(2025).

How can cervical screening meet the needs of vulnerable women? A qualitative comparative study with stakeholder perspectives from seven European countries.

Bøje, RB; Bardou, M; Mensah, K; Rico Berrocal, R; Bonvicini, L; Iorio, G; Auzzi, N; Taut, D; Pașca, N-M; Tisler, A; Reintamm, K; Uusküla, A; Teixeira, M; Firmino-Machado, J; Amorim, M; Baia, I; Lunet, N; Panayotova, Y; Kotzeva, T; Todorova, I; Andersen, B; Kirkegaard, P; CBIG-SCREEN Consortium,;

2025

BMJ open, (2025).15 1 10.1136/bmjopen-2024-090631.

Tools and challenges in the use of routine clinical data for antimicrobial resistance surveillance.

Holt, KE; Carey, ME; CHANDLER, C; CROSS, JH; Dyson, ZA; FURNHAM, N; GLOVER, RE; Virgo, M; KNIGHT, GM;

2025

npj antimicrobials and resistance, (2025).3 1 10.1038/s44259-025-00105-3.

Spatial prediction of immunity gaps during a pandemic to inform decision making: A geostatistical case study of COVID-19 in Dominican Republic.

Cadavid Restrepo, A; Martin, BM; Mayfield, HJ; Paulino, CT; De St Aubin, M; Duke, W; Jarolim, P; Oasan, T; Gutiérrez, EZ; Ramm, RS; Dumas, D; Garnier, S; Etienne, MC; Peña, F; Abdalla, G; Lopez, B; De la Cruz, L; Henriquez, B; Baldwin, M; KUCHARSKI, A; Sartorius, B; Nilles, EJ; Lau, CL;

2025

Tropical medicine & international health : TM & IH, (2025).30 5 10.1111/tmi.14094.